Search hospitals > Iowa > Ames
McFarland Clinic PC - Ames
Claim this profileAmes, Iowa 50010
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Adenocarcinoma
268 reported clinical trials
3 medical researchers
Summary
McFarland Clinic PC - Ames is a medical facility located in Ames, Iowa. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Adenocarcinoma and other specialties. McFarland Clinic PC - Ames is involved with conducting 268 clinical trials across 388 conditions. There are 3 research doctors associated with this hospital, such as Debra M. Prow, Joseph J. Merchant, and Christina Taylor, MD.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderStage IV
ER positive
HER2 negative
Top PIs
Debra M. ProwMcFarland Clinic PC - Ames4 years of reported clinical research
Expert in Cancer
Expert in Lung Cancer
125 reported clinical trials
185 drugs studied
Joseph J. MerchantMcFarland Clinic - Ames4 years of reported clinical research
Expert in Cancer
Expert in Lung Cancer
88 reported clinical trials
141 drugs studied
Christina Taylor, MDMcFarland Clinic2 years of reported clinical research
Studies Dementia
1 reported clinical trial
1 drug studied
Clinical Trials running at McFarland Clinic PC - Ames
Breast Cancer
Lung Cancer
Cancer
Non-Small Cell Lung Cancer
Melanoma
Bladder Cancer
Prostate Cancer
Renal Cell Carcinoma
Squamous Cell Carcinoma
Bladder Carcinoma
Hormone Therapy with or without Radiation
for Breast Cancer
This Phase III Trial evaluates whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.
Recruiting2 awards Phase 313 criteria
Support Program
for Breast Cancer
This phase III trial compares an additional support program (text message reminders and/or telephone-based counseling) with usual care in making sure breast cancer patients take their endocrine therapy medication as prescribed (medication adherence). Medication adherence is how well patients take the medication as prescribed by their doctors, and good medical adherence is when patients take medications correctly. Poor medication adherence has been shown to be a serious barrier to effective treatment for hormone receptor positive breast cancer patients. Adding text message reminders and/or telephone-based counseling to usual care may increase the number of days that patients take their endocrine therapy medication as prescribed.
Recruiting2 awards Phase 34 criteria
Sacituzumab Govitecan
for Brain Metastases from Breast Cancer
This phase II trial studies the effect of sacituzumab govitecan in treating patients with HER2-negative breast cancer that has spread to the brain (brain metastases). Sacituzumab govitecan is a monoclonal antibody, called sacituzumab, linked to a chemotherapy drug, called govitecan. Sacituzumab is a form of targeted therapy because it attaches to specific molecules on the surface of cancer cells, known as Trop-2 receptors, and delivers govitecan to kill them. Giving sacituzumab govitecan may shrink the cancer in the brain and/or extend the time until the cancer gets worse.
Recruiting1 award Phase 212 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at McFarland Clinic PC - Ames?
McFarland Clinic PC - Ames is a medical facility located in Ames, Iowa. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Adenocarcinoma and other specialties. McFarland Clinic PC - Ames is involved with conducting 268 clinical trials across 388 conditions. There are 3 research doctors associated with this hospital, such as Debra M. Prow, Joseph J. Merchant, and Christina Taylor, MD.